Inventor
PENDERGAST WILLIAM
US48 patents
⚠️ This page may combine multiple inventors who share the name “PENDERGAST WILLIAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INSPIRE PHARMACEUTICALS INC
28 patentsUS5900407AMay 4, 1999
Method of treating dry eye disease with uridine triphosphates and related compounds
INSPIRE PHARMACEUTICALS INC121 citations99
US5837861ANov 17, 1998
Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
INSPIRE PHARMACEUTICALS INC102 citations97
US5789391AAug 4, 1998
Method of treating sinusitis with uridine triphosphates and related compounds
INSPIRE PHARMACEUTICALS INC205 citations97
US6348589B1Feb 19, 2002
Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
INSPIRE PHARMACEUTICALS INC67 citations95
US5981506ANov 9, 1999
Method for treating sinusitis with uridine triphosphates and related compounds
INSPIRE PHARMACEUTICALS INC39 citations94
US5972904AOct 26, 1999
Method of treating sinusitis with uridine triphosphates and related compounds
INSPIRE PHARMACEUTICALS INC41 citations94
US5958897ASep 28, 1999
Method of treating sinusitis with uridine triphosphates and related compounds
INSPIRE PHARMACEUTICALS INC43 citations94
US6713458B1Mar 30, 2004
Therapeutic uses of di(uridine 5′)-tetraphosphate and salts thereof
INSPIRE PHARMACEUTICALS INC32 citations93
US6323187B1Nov 27, 2001
Therapeutic dinucleotide and derivatives
INSPIRE PHARMACEUTICALS INC72 citations93
US6319908B1Nov 20, 2001
Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
INSPIRE PHARMACEUTICALS INC41 citations93
US7531525B2May 12, 2009
P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating cystic fibrosis
INSPIRE PHARMACEUTICALS INC21 citations92
US7223744B2May 29, 2007
Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
INSPIRE PHARMACEUTICALS INC34 citations92
US6977246B2Dec 20, 2005
Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
INSPIRE PHARMACEUTICALS INC31 citations92
US6887858B1May 3, 2005
Method of treating dry eye disease with purinergic receptor agonists
INSPIRE PHARMACEUTICALS INC28 citations92
US6696425B2Feb 24, 2004
Method of treating dry eye disease with purinergic receptor agonists
INSPIRE PHARMACEUTICALS INC28 citations92
US6624150B2Sep 23, 2003
Method of treating gastrointestinal tract disease with purinergic receptor agonists
INSPIRE PHARMACEUTICALS INC35 citations91
US6420347B1Jul 16, 2002
Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
INSPIRE PHARMACEUTICALS INC32 citations90
US5968913AOct 19, 1999
Pharmaceutical compositions of uridine triphosphate
INSPIRE PHARMACEUTICALS INC29 citations90
US6462028B2Oct 8, 2002
Method of promoting cervical and vaginal secretions
INSPIRE PHARMACEUTICALS INC18 citations84
US6916794B2Jul 12, 2005
Method of enhancing drainage of lacrimal system with purinergic receptor agonists
INSPIRE PHARMACEUTICALS INC11 citations82
US6673779B2Jan 6, 2004
Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues
INSPIRE PHARMACEUTICALS INC19 citations80
US7759322B2Jul 20, 2010
Method of treating dry eye disease with purinergic receptor agonists
INSPIRE PHARMACEUTICALS INC6 citations74
US7235535B2Jun 26, 2007
Method of enhancing drainage of lacrimal system with purinergic receptor agonists
INSPIRE PHARMACEUTICALS INC4 citations74
US6921755B2Jul 26, 2005
Method of treating dry eye disease with purinergic receptor agonists
INSPIRE PHARMACEUTICALS INC9 citations74
US6765090B2Jul 20, 2004
Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
INSPIRE PHARMACEUTICALS INC5 citations74
US8008274B2Aug 30, 2011
P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis
INSPIRE PHARMACEUTICALS INC0 citations52
US7091334B2Aug 15, 2006
Method for large-scale production of di(uridine 5′)-tetraphosphate and salts thereof
INSPIRE PHARMACEUTICALS INC0 citations52
US7432252B1Oct 7, 2008
Method of promoting cervical and vaginal secretions
INSPIRE PHARMACEUTICALS INC1 citations51
CHANG KWEN-JEN
5 patentsUS9701645B2Jul 11, 2017
Method of treating Parkinson's disease with a diarylmethylpiperazine compounds exhibiting delta opioid receptor agonist activity
CHANG KWEN-JEN2 citations69
US8642599B2Feb 4, 2014
Method of treating Parkinson's Disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
CHANG KWEN-JEN2 citations59
US8575169B2Nov 5, 2013
Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
CHANG KWEN-JEN0 citations48
US8476280B2Jul 2, 2013
Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
CHANG KWEN-JEN0 citations48
US8551998B2Oct 8, 2013
Delta opioid receptor agonist compounds
CHANG KWEN-JEN0 citations46
GLAXO WELLCOME INC
4 patentsUS5663337ASep 2, 1997
Pharmaceutically active benzoquinazoline compounds
GLAXO WELLCOME INC4 citations74
US5661155AAug 26, 1997
Treatment of cancer with pharmaceutically active benzoquinazoline compounds
GLAXO WELLCOME INC5 citations74
US6306865B1Oct 23, 2001
Pharmaceutically active benzoquinazoline compounds
GLAXO WELLCOME INC12 citations71
US6090941AJul 18, 2000
Pharmaceutically active benzoquinazoline compounds
GLAXO WELLCOME INC1 citations60
UNIV NORTH CAROLINA
3 patentsUS6143279ANov 7, 2000
Uridine 5'-diphosphate and analogs useful for treating lung diseases
UNIV NORTH CAROLINA57 citations94
US6022527AFeb 8, 2000
Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof
UNIV NORTH CAROLINA58 citations94
US6451288B1Sep 17, 2002
Method of treating lung diseases with uridine 5′-diphosphate and analogs thereof
UNIV NORTH CAROLINA32 citations91
VERSI GROUP LLC
3 patentsUS9296707B2Mar 29, 2016
Delta opioid receptor agonist compounds
VERSI GROUP LLC1 citations57
US10071093B2Sep 11, 2018
Method of treating Parkinson's Disease with a diarylmethylpiperazine compounds exhibiting delta opioid receptor agonist activity
VERSI GROUP LLC0 citations48
US8865721B2Oct 21, 2014
Delta opioid receptor agonist compounds
VERSI GROUP LLC0 citations45